Tobramycin
ArticlesRefrigerated StorageLactation Safety Information · Published , updatedArticles
Safety in Lactation: Anti-infective eye preparations
Anti-infective preparations for ophthalmic use have limited systemic absorption in the mother, and pose negligible risk to a breastfed infant. Systemic absorption from eye drops… Aciclovir Azithromycin Chloramphenicol Ciprofloxacin Fusidic acid Ganciclovir Gentamicin Levofloxacin Moxifloxacin Ofloxacin TobramycinAdministration of tobramycin via a nebuliser
If there are robust clinical reasons to administer tobramycin injection via a nebuliser instead of using the licensed nebuliser solution then it is critical that… Respiratory disorders TobramycinWhich commonly used nebuliser solutions are compatible?
Mixing of nebuliser solutions should only be undertaken in the best interests of the patient and only by a person competent and willing to do… Budesonide Colistimethate Fluticasone Ipratropium Respiratory disorders Salbutamol Salbutamol + Ipratropium Terbutaline TobramycinHow should medicines be dosed in children who are obese?
Obesity results in physiological changes that can affect the volume of distribution and the clearance of drugs. The extent of these changes is variable and… Aciclovir Aminophylline Benzylpenicillin Carbamazepine Clindamycin Dosing Enoxaparin Esomeprazole Gentamicin Heparin Ibuprofen Metronidazole Morphine Omeprazole Ondansetron Paediatrics and neonates Paracetamol Phenobarbital Phenobarbital sodium Phenoxymethylpenicillin Phenytoin Phenytoin sodium Prednisolone Ranitidine Theophylline Tobramycin VancomycinSafety in Lactation: Non-beta lactam antibiotics and antibacterials
paedAdditional information relating to breastfeeding To be used in conjunction with individual drug entries for specific information and guidance. Aminoglycosides Only small or negligible amounts… Amikacin Gentamicin Infection and infectious diseases Neomycin Obstetrics and gynaecology Paediatrics and neonates Safety in Breastfeeding Streptomycin TobramycinRefrigerated Storage
TobiMylan
In the event of an inadvertent temperature excursion the following data may be used:
After removal from the refrigerator, or if refrigeration is unavailable, TOBI pouches (intact or opened) may be stored at up to 25°C for up to 28 days.
Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk.
Contact Mylan in all cases where a deviation from the recommended storage conditions has occurred. Refer to the current BNF for company contact details.
BramitobChiesi
In the event of an inadvertent temperature excursion the following data may be used:
After first opening the single-dose container: use immediately.
In use shelf life: Bramitob bags (intact or opened) may be stored for up to 3 months at not more than 25°C by the end user
Prior to dispensing: Contact Chiesi in all cases where a deviation from the recommended storage conditions has occurred. Refer to the current BNF for company contact details.
Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk
VantobraPARI Pharma GmbH
The manufacturer does not hold stability data in addition to that provided in the Summary of Product Characteristics (SPC).
Please refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk
Lactation Safety Information
Parenteral / Inhalation
No aminoglycoside alternative for inhalation use